News
The latest research and industry developments in weight management, metabolism, and GLP-1 medications, updated regularly.
Gallup: 11% of Americans Now Take GLP-1 Drugs as Obesity Rate Declines
Gallup's latest National Health and Well-Being Index finds GLP-1 weight-loss drug use has nearly quadrupled since 2024, coinciding with a multi-point drop in the U.S. adult obesity rate.
Read More →Medicare's New GLP-1 Bridge Program Begins, Capping Costs at $50 a Month
A new CMS demonstration program gives eligible Medicare beneficiaries access to certain GLP-1 weight-loss drugs for a capped monthly out-of-pocket cost, running through the end of 2027.
Read More →WHO Cancer Research Arm Finds Blood 'Signature' Linked to Ultra-Processed Food Intake
Researchers at the WHO's International Agency for Research on Cancer identified a distinct pattern of blood metabolites linked to ultra-processed food intake, using metabolomics rather than self-reported diet data.
Read More →New Oral GLP-1 Pill Shows Up to 12% Weight Loss in Phase 2 Trial
A randomized, placebo-controlled trial published in Nature Medicine found the experimental oral GLP-1 drug aleniglipron produced dose-dependent weight loss of up to 12% over 36 weeks.
Read More →Data Show Two-Thirds of Lost Weight Returns Within a Year of Stopping Semaglutide
New follow-up data on patients who stopped taking semaglutide or tirzepatide show an average regain of nearly two pounds per month, with the STEP 1 extension finding two-thirds of lost weight returned within a year.
Read More →New NHANES Study Links Ultra-Processed Food Intake to Higher Mortality Risk
A large NHANES-based study published in the American Journal of Public Health adds to evidence linking ultra-processed food consumption with cardiometabolic health risk and mortality.
Read More →Eli Lilly's Experimental GLP-1 Shows 28% Weight Loss -- and New Questions About Risk
New data from Eli Lilly show an experimental GLP-1 medicine driving average weight loss of 28% of body weight, a substantial jump from currently available drugs, alongside physician concern about the tradeoffs of greater potency.
Read More →Study: 8,500 Daily Steps May Be the Sweet Spot for Preventing Weight Regain
New meta-analysis data presented at ECO 2026 in Istanbul found that reaching and sustaining about 8,500 daily steps was linked to significantly better weight-loss maintenance than lower step counts.
Read More →Meta-Analysis Confirms Higher Protein Intake Preserves Muscle During Weight Loss
A large systematic review and meta-analysis found that protein intake above the standard RDA meaningfully protects against muscle loss during weight-loss efforts in adults with overweight or obesity.
Read More →Study Finds Intermittent Fasting Offers No Metabolic Benefit Without a Calorie Deficit
A randomized study from German and Berlin-based researchers found that time-restricted eating alone -- without reducing overall calorie intake -- does not improve metabolic or cardiovascular health markers.
Read More →